Clinical Trial Update: A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Disitamab Vedotin for advanced HER2-positive Paget's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extramammary Paget Disease
• Mammary Paget Disease

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)

Snippet

Sponsor: Fudan University | Conditions: Mammary or Extramammary Paget's Disease | Phase 2 | Status: RECRUITING